Post-Market Clinical Investigation of the Clareon® IOL

NACompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

October 18, 2019

Study Completion Date

September 23, 2021

Conditions
CataractAphakia
Interventions
DEVICE

Clareon® IOL

Foldable, single-piece posterior chamber IOL intended for long-term use over the lifetime of the cataract patient. This device is CE-marked (European Conformity) in the countries with participating Investigators.

PROCEDURE

Cataract Surgery

Routine small incision cataract surgery with unilateral IOL implantation

Trial Locations (19)

2067

Alcon Investigative Site, Sydney

3011

Alcon Investigative Site, Footscray

3931

Alcon Investigative Site, Mornington

11408

Alcon Investigative Site, Jerez de la Frontera

20014

Alcon Investigative Site, San Sebastián

28805

Alcon Investigative Site, Alcalá de Henares

29609

Alcon Investigative Site, Brest

33012

Alcon Investigative Site, Oviedo

46015

Alcon Investigative Site, Valencia

56124

Alcon Investigative Site, Pisa

60590

Alcon Investigative Site, Frankfurt

69003

Alcon Investigative Site, Lyon

69120

Alcon Investigative Site, Heidelberg

75014

Alcon Investigative Site, Paris

06129

Alcon Investigative Site, Perugia

1105AZ

Alcon Investigative Site, Amsterdam

SM5 1AA

Alcon Investigative Site, Sutton

BN2 5BF

Alcon Investigative Site, Brighton

EC1V2PD

Alcon Investigative Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT03316885 - Post-Market Clinical Investigation of the Clareon® IOL | Biotech Hunter | Biotech Hunter